Fny Investment Advisers, LLC Procaps Group, S.A. Transaction History

Fny Investment Advisers, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 19, 2022	SELL	$0.8 - $8.85 $160 - $1,770	-200 Reduced 28.57%	500 $3,000
Q2 2022 Jul 12, 2022	BUY	$7.33 - $9.4 $5,131 - $6,580	700 New	700 $6,000
Q1 2022 Apr 25, 2022	SELL	$7.97 - $9.85 $25,504 - $31,520	-3,200 Closed	0 $0
Q4 2021 Jan 10, 2022	BUY	$8.85 - $10.42 $1,770 - $2,084	200 Added 6.67%	3,200 $31,000
Q3 2021 Oct 13, 2021	BUY	$9.25 - $10.76 $27,750 - $32,280	3,000 New	3,000 $30,000

195K

Ticker PROC
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 112,824,000
Market Cap $196M
Description
Procaps Group S.A. develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and ...

Get notified when there are updates to the investment portfolio of Fny Investment Advisers, LLC, based on Form 13F filings with the SEC.

Stay updated on Fny Investment Advisers, LLC with notifications on news.